S9716: Combination Chemotherapy in Treating Patients With Merkel Cell Cancer
Status:
Completed
Trial end date:
2003-01-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die. Combining more than one drug may kill more tumor cells.
PURPOSE: Phase II trial to study the effectiveness of combining cyclophosphamide,
methotrexate, and fluorouracil in treating patients with Merkel cell cancer.